Van Wilder, Philippe <br/><br/>
Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium.  [electronic resource] 

 -  European journal of clinical pharmacology  Jul 2019 
 - 895-900 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-1041 
<br/><br/><label>Standard No.: </label>10.1007/s00228-019-02665-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Belgium<br/>Decision Making<br/>Pharmaceutical Preparations--economics<br/>Reimbursement Mechanisms<br/>Technology Assessment, Biomedical